Mrna could top $600!!!

2021-08-31

He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday at $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. BioNTech already trades at best-case levels, he wrote. $Moderna, Inc.(MRNA)$ $Pfizer(PFE)$ $BioNTech SE(BNTX)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":818609443,"tweetId":"818609443","gmtCreate":1630399861378,"gmtModify":1630399861378,"author":{"id":3479274729583717,"idStr":"3479274729583717","authorId":3479274729583717,"authorIdStr":"3479274729583717","name":"richegg","avatar":"https://static.laohu8.com/picture62","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Mrna could top $600!!!","extraTitle":"","html":"<html><head></head><body><p>He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday at $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. BioNTech already trades at best-case levels, he wrote.&nbsp;<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> <a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a> <a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a> </p></body></html>","htmlText":"<html><head></head><body><p>He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday at $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. BioNTech already trades at best-case levels, he wrote.&nbsp;<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> <a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a> <a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a> </p></body></html>","text":"He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday at $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. BioNTech already trades at best-case levels, he wrote. $Moderna, Inc.(MRNA)$ $Pfizer(PFE)$ $BioNTech SE(BNTX)$","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/818609443","repostId":0,"isVote":1,"tweetType":1,"viewCount":1862,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BNTX","MRNA","PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":351,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/818609443"}